Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP322391.RAaf829jyXfqK3n8nhDY_pzzj1eBqJQRWPsA1lPTrL9UI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP322391.RAaf829jyXfqK3n8nhDY_pzzj1eBqJQRWPsA1lPTrL9UI130_assertion type Assertion NP322391.RAaf829jyXfqK3n8nhDY_pzzj1eBqJQRWPsA1lPTrL9UI130_head.
- NP322391.RAaf829jyXfqK3n8nhDY_pzzj1eBqJQRWPsA1lPTrL9UI130_assertion description "[Here, we report that GATA-2 is expressed in a substantial proportion of prostate cancers and that high expression of GATA-2 is associated with biochemical recurrence and distant metastatic progression in a validation set of 203 cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP322391.RAaf829jyXfqK3n8nhDY_pzzj1eBqJQRWPsA1lPTrL9UI130_provenance.
- NP322391.RAaf829jyXfqK3n8nhDY_pzzj1eBqJQRWPsA1lPTrL9UI130_assertion evidence source_evidence_literature NP322391.RAaf829jyXfqK3n8nhDY_pzzj1eBqJQRWPsA1lPTrL9UI130_provenance.
- NP322391.RAaf829jyXfqK3n8nhDY_pzzj1eBqJQRWPsA1lPTrL9UI130_assertion SIO_000772 19684615 NP322391.RAaf829jyXfqK3n8nhDY_pzzj1eBqJQRWPsA1lPTrL9UI130_provenance.
- NP322391.RAaf829jyXfqK3n8nhDY_pzzj1eBqJQRWPsA1lPTrL9UI130_assertion wasDerivedFrom befree-20140225 NP322391.RAaf829jyXfqK3n8nhDY_pzzj1eBqJQRWPsA1lPTrL9UI130_provenance.
- NP322391.RAaf829jyXfqK3n8nhDY_pzzj1eBqJQRWPsA1lPTrL9UI130_assertion wasGeneratedBy ECO_0000203 NP322391.RAaf829jyXfqK3n8nhDY_pzzj1eBqJQRWPsA1lPTrL9UI130_provenance.